Advertisement
argenx SE

argenx SE (ARGX) Stock Overview

Explore argenx SE’s financial performance, market position, analyst ratings, and future outlook.

ARGXNASDAQ
HealthcareBiotechnology
$862.93
$3.50(0.41%)
U.S. Market opens in 16h 10m
Advertisement

argenx SE (ARGX)

Meyka AI Score

Z

Key Financials

Market Cap54B
P/E Ratio36.26
EPS (TTM)$11.08
ROE0.22%
Fundamental Analysis

AI Price Forecasts

1 Month$987.89
3 Months$959.74
1 Year Target$858.16

ARGX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of argenx SE (ARGX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.55, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $858.16.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 36.26 and a market capitalization of 54B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.41%
5-Day Change
-4.63%
1-Month Change
-2.41%
3-Month Change
2.62%
6-Month Change
6.11%
Year-to-Date (YTD) Change
2.61%
1-Year Change
55.21%
3-Year Change
78.13%
5-Year Change
187.23%
All-Time (Max) Change
3651.87%

Contact Information

31 10 703 8441
Laarderhoogtweg 25, Amsterdam, NH, 1101EB

Company Facts

18,630 Employees
IPO DateMay 18, 2017
CountryNL
Actively Trading

Frequently Asked Questions